-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Vaxcyte, Maintains $110 Price Target

Benzinga·09/25/2026 10:15:43
Listen to the news
Needham analyst Joseph Stringer reiterates Vaxcyte (NASDAQ:PCVX) with a Buy and maintains $110 price target.